Celldex Therapeutics (NasdaqCM:CLDX) FY Conference Transcript
Celldex Therapeutics (NasdaqCM:CLDX) FY Conference September 09, 2025 03:20 PM ET Company ParticipantsAnthony Marucci - CEOTibor Keler - CSODiane Young - CMOConference Call ParticipantsJudah Fromer - AnalystJudah FromerEveryone, to this session of the Morgan Stanley Global Healthcare Conference, I'm Judah Fromer, one of the Biotech Analysts here. Let me just read a quick disclosure before welcoming the Celldex team. For important disclosures, please see the Morgan Stanley Research Disclosure website at www. ...